LS Investment Advisors’s Bioverativ Inc. Common Stock BIVV Stock Holding History

LS Investment Advisors’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-8,929	Closed	-$481K	–	1903
2017 Q4	$481K	Sell	8,929 -33	-0.4%	-$1.81K	0.03%	513
2017 Q3	$511K	Sell	8,962 -241	-3%	-$14.1K	0.03%	506
2017 Q2	$554K	Buy	9,203 +1,436	+18%	+$81.8K	0.03%	455
2017 Q1	$423K	Buy	+7,767	New	+$383K	0.03%	534

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

LS Investment Advisors's BIVV Position: Q1 2018 in Review

LS Investment Advisors sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 8,929 shares — an estimated $481K sold.

LS Investment Advisors first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $554K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

LS Investment Advisors reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
LS Investment Advisors sold 8,929 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $481K.
LS Investment Advisors first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
LS Investment Advisors's Bioverativ Inc. Common Stock position peaked at $554K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on LS Investment Advisors's 13F filing for Q1 2018, filed 8 May 2018.